Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

NCT05371093

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Stanford Health Care Stanford, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Kansas Hospital Westwood, Kansas, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies

NCT05270057

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University of Texas Southwestern Dallas, Texas, United States
  • University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

NCT02153580

Conditions
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View Trial Details

Related conditions